Skin cell function in HS patients
Part of Infections, Skin clinical trials.
This study looks at how skin cells work in people with hidradenitis suppurativa (HS), a condition that causes painful lumps under the skin. It aims to understand the disease better, which might lead to improved treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hidradenitis suppurativa (HS)
- You are willing and able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study looks at what causes hidradenitis suppurativa (HS) in the body. It may help researchers understand the condition better and could lead to better treatments.
This study explores how people with hidradenitis suppurativa (HS) participate in research. You'll report your health regularly using a device, and the goal is to better understand patient experiences.
This study looks at how “stress” inside skin cells may be connected to hidradenitis suppurativa, a long-term painful skin condition with recurrent bumps and tunnels. Your participation may help researchers understand what drives the disease.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This study enrolls people with hidradenitis suppurativa (HS) to better understand the condition over time and store optional health information and samples. Being in the registry may help researchers learn about patterns in HS and support future research.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.